Professor Stefan H Hohnloser
Johann Wolfgang Goethe University, Frankfurt (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Anticoagulation management in non-valvular atrial fibrillation: optimising patient outcomes
Event: ESC Congress 2020
Topic: Oral Anticoagulation
Session type: Industry Q&A session
Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation
Event: ESC Congress 2019
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?
Event: EHRA 2019
Topic: Stroke Treatment, Other
Session type: Satellite Symposium
Optimizing stroke prevention with NOACs: focus on Atrial Fibrillation (AF) patients with concomitant Acute Coronary Syndrome (ACS)
Event: EHRA 2019
Topic: Oral Anticoagulation
Session type: Satellite Symposium
Stroke prevention in atrial fibrillation: discussing optimal care with NOACs for complex patients
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium - Experts on the Spot
Cancer therapy and arrhythmias
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Pharmacology
Session type: Symposium
State-of-the-art: Atrial Fibrillation (AF) ablation in patients on NOACs
Event: ESC Congress 2015
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium - Experts on the Spot
Exploring the universe of oral anticoagulation in patients with non-valvular atrial fibrillation: continuing the journey
Event: ESC Congress 2015
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
The thrombosis versus bleeding risk dilemma: practical considerations with oral factor Xa inhibition
Event: ESC CONGRESS 2014
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium - Experts on the Spot
ESC 365 is supported by
